Maya K. Desai, Ph.D. - Publications
Affiliations: | Stanford University, Palo Alto, CA |
Area:
Alzheimer, myelin, oligodendrocytesYear | Citation | Score | |||
---|---|---|---|---|---|
2011 | Desai MK, Guercio BJ, Narrow WC, Bowers WJ. An Alzheimer's disease-relevant presenilin-1 mutation augments amyloid-beta-induced oligodendrocyte dysfunction. Glia. 59: 627-40. PMID 21294162 DOI: 10.1002/Glia.21131 | 0.72 | |||
2010 | Desai MK, Mastrangelo MA, Ryan DA, Sudol KL, Narrow WC, Bowers WJ. Early oligodendrocyte/myelin pathology in Alzheimer's disease mice constitutes a novel therapeutic target. The American Journal of Pathology. 177: 1422-35. PMID 20696774 DOI: 10.2353/Ajpath.2010.100087 | 0.698 | |||
2010 | Bowers WJ, Desai MK, Mastrangelo MA, Ryan DA, Sudol KL, Narrow WC. P2-242: Oligodendrocyte cell lineage represents an amyloid beta 1-42 sensitive cell population leading to white matter alterations during early Alzheimer's disease Alzheimer's & Dementia. 6: S385-S385. DOI: 10.1016/J.Jalz.2010.05.1291 | 0.637 | |||
2009 | Desai MK, Sudol KL, Janelsins MC, Mastrangelo MA, Frazer ME, Bowers WJ. Triple-transgenic Alzheimer's disease mice exhibit region-specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathology. Glia. 57: 54-65. PMID 18661556 DOI: 10.1002/Glia.20734 | 0.703 | |||
2008 | Desai MK, Sudol KL, Janelsins MC, Mastrangelo MA, Frazer ME, Bowers WJ. P3-404: Triple-transgenic Alzheimer's disease mice exhibit marked abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathology Alzheimer's & Dementia. 4: T640-T640. DOI: 10.1016/J.Jalz.2008.05.1975 | 0.687 | |||
Show low-probability matches. |